HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome

Hepatology International
Angelo AndriulliT Santantonio

Abstract

To evaluate similarities and differences in HCV-1 subtypes 1a and 1b in the presenting clinical features and the response to peg-interferon and ribavirin (Peg/RIBA). A total of 1,233 naïve patients with HCV genotype-1 infection, 159 (13%) with subtype 1a and 1,074 (87%) with subtype 1b were treated with Peg-IFN/RIBA at 12 Italian centers. Covariates included in the logistic model were age, gender, BMI, serum alanine aminotransferase, serum gamma-glutamiltranspeptidase (γGT), platelets counts, liver fibrosis, the occurrence of type 2 diabetes, baseline viremia, and IL28B genotype. At multivariate analysis, baseline characteristics differentiating patients with HCV-1a versus HCV-1b were young age, male gender, no F4 fibrosis, and no diabetes. SVR was achieved by 37% of patients with subtype 1b and 45% of those with subtype 1a, a nonsignificant difference of 8% (p = 0.069). In patients with subtype 1a, predictors of SVR were IL28B CC (OR 5.78, CI 1.98-16.83), RVR (OR 4.18, CI 1.66-10.55), female gender (OR 2.83, CI 1.83-6.78), and HCVRNA (OR 0.55, CI 0.32-0.96). In patients with subtype 1b, the ranking of predictors was levels RVR (OR 6.49, CI 4.32-9.73), IL28B CC (OR 3.32, CI 2.15-4.58), γGT (OR 1.59, CI 0.14-2.22), HCVRNA (OR 0....Continue Reading

References

Jan 1, 1987·Epidemiologic Reviews·S Greenland
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Mar 5, 2004·Annals of Internal Medicine·Stephanos J HadziyannisUNKNOWN PEGASYS International Study Group
Sep 9, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Peter SimmondsAnders Widell
Aug 8, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tara L KiefferStefan Zeuzem
Nov 15, 2008·Methods in Molecular Biology·Carla Kuiken, Peter Simmonds
Mar 11, 2009·Antimicrobial Agents and Chemotherapy·Matthew F McCownIsabel Nájera
Apr 12, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ingrid Imhof, Peter Simmonds
Jun 18, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Markus CornbergStefan Zeuzem
Jun 24, 2011·The New England Journal of Medicine·Ira M JacobsonUNKNOWN ADVANCE Study Team
Sep 8, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marc G GhanyUNKNOWN American Association for Study of Liver Diseases
Sep 16, 2011·The New England Journal of Medicine·Kenneth E ShermanUNKNOWN ILLUMINATE Study Team
Nov 20, 2012·BMC Gastroenterology·Adriano M PellicelliUNKNOWN CLEO Group
Dec 22, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·James E Everhart, Elizabeth C Wright
Jun 24, 2014·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Angelo AndriulliUNKNOWN Collaborators

❮ Previous
Next ❯

Citations

Mar 20, 2015·Hepatology International·Mohammed Eslam, Jacob George
Dec 23, 2016·Expert Review of Anti-infective Therapy·Carolina ScagnolariGuido Antonelli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.